1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch
Book a demo
-
  1. My Preqin
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch
  1. My Preqin
Book a demo

Junhemeng Biopharmaceutical (Hangzhou)

Have updates for this profile?  Please contribute data

About
= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Year established

2020

Location

Hangzhou Zhejiang China

Primary Industry

Biotechnology

About

Based in Hangzhou, China, and established in 2020, Junhemeng Biopharmaceutical (Hangzhou) is a biopharmaceutical company that focuses on the R&D of recombinant protein drugs. It established approximately 8,000 square meters of GMP-level production bases in Hangzhou. In May 2024, Junhemeng Biopharmaceutical (Hangzhou) raised a series B funding for CNY 100 million. In September 2024, the firm raised approximately CNY 250 million in series B+ funding. Junhemeng Biopharmaceutical (Hangzhou) developed recombinant protein R&D platforms, covering recombinant protein express systems, separation and purification technologies, protein in vitro folding and self-assembly systems, and drug Long-lasting slow-release control technologies. Products include recombinant human collagen, recombinant botulinum toxin type A, recombinant growth hormone, etc. The company generates revenue by providing recombinant protein drugs. The company will use the series B+ funding for further advancing the development of the company's product pipeline and accelerating the industrialization and commercialization of the company's product pipeline.
Current Investors
Zhongtou Zhongcai Capital, Guangdian Capital, WinX Capital

Request a demo to show more

Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals, Molecular Science, Genetics & Gene Therapy, Healthcare IT, Pharmaceutical Research & Development
Verticals
HealthTech
Company Stage
Series B
Total Amount Raised
Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.
Sign in Request demo